{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:09:41Z","timestamp":1786234181249,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIHR Cambridge Biomedical Research Center","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"NIHR Cambridge Biomedical Research Center","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"NIHR Cambridge Biomedical Research Center","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"NIHR Cambridge Biomedical Research Center","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"NIHR Cambridge Biomedical Research Center","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}]},{"name":"Wellcome Trust Institutional Strategic Support Fund, University of Cambridge"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Management of Cushing\u2019s disease is informed by dedicated imaging of the sella and parasellar regions. Although magnetic resonance imaging (MRI) remains the investigation of choice, a significant proportion (30\u201350%) of corticotroph tumours are so small as to render MRI indeterminate or negative when using standard clinical sequences. In this context, alternative MR protocols [e.g. 3D gradient (recalled) echo, with acquisition of volumetric data] may allow detection of tumors that have not been previously visualized. The use of hybrid molecular imaging (e.g. <jats:sup>11<\/jats:sup>C-methionine positron emission tomography coregistered with volumetric MRI) has also been proposed as an additional modality for localizing microadenomas.<\/jats:p>","DOI":"10.1007\/s11102-022-01236-w","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T09:47:08Z","timestamp":1654508828000},"page":"709-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Modern imaging in Cushing\u2019s disease"],"prefix":"10.1007","volume":"25","author":[{"given":"W. A.","family":"Bashari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Powlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Kolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Scoffings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. A.","family":"Mendichovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. K.","family":"Cheow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Koulouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101513","author":"R Senanayake","year":"2021","unstructured":"Senanayake R, Gillett D, MacFarlane J, Van de Meulen M, Powlson A, Koulouri O et al (2021) New types of localization methods for adrenocorticotropic hormone-dependent Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2021.101513","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1236_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13123","author":"J Bonneville","year":"2022","unstructured":"Bonneville J, Potorac I, Petrossians P, Tshibanda L, Beckers A (2022) Pituitary MRI in Cushing\u2019s disease-an update. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13123","journal-title":"J Neuroendocrinol"},{"key":"1236_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1236_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1365-2265.2009.03723.x","volume":"72","author":"D Erickson","year":"2010","unstructured":"Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F et al (2010) 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 72:793\u2013799. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03723.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1236_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/cen.12069","volume":"78","author":"R Kasaliwal","year":"2013","unstructured":"Kasaliwal R, Sankhe SS, Lila AR, Budyal SR, Jagtap VS, Sarathi V et al (2013) Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas. Clin Endocrinol (Oxf) 78:825\u2013830. https:\/\/doi.org\/10.1111\/cen.12069","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1236_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3171\/2017.3.JNS163122","volume":"128","author":"Y Grober","year":"2018","unstructured":"Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH (2018) Comparison of MRI techniques for detecting microadenomas in Cushing\u2019s disease. J Neurosurg 128:1051\u20131057. https:\/\/doi.org\/10.3171\/2017.3.JNS163122","journal-title":"J Neurosurg"},{"key":"1236_CR7","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1038\/s41598-020-71628-0","volume":"10","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang X, Wang Z, You H, Li M, Feng F et al (2020) High positive predictive value of the combined pituitary dynamic enhanced MRI and high-dose dexamethasone suppression tests in the diagnosis of Cushing\u2019s disease bypassing bilateral inferior petrosal sinus sampling. Sci Rep 10:14694. https:\/\/doi.org\/10.1038\/s41598-020-71628-0","journal-title":"Sci Rep"},{"key":"1236_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3171\/2017.4.JNS17234","volume":"129","author":"GP Chatain","year":"2018","unstructured":"Chatain GP, Patronas N, Smirniotopoulos JG, Piazza M, Benzo S, Ray-Chaudhury A et al (2018) Potential utility of FLAIR in MRI-negative Cushing\u2019s disease. J Neurosurg 129:620\u2013628. https:\/\/doi.org\/10.3171\/2017.4.JNS17234","journal-title":"J Neurosurg"},{"key":"1236_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1055\/s-0038-1642032","volume":"79","author":"M Lang","year":"2018","unstructured":"Lang M, Habboub G, Moon D, Bandyopadhyay A, Silva D, Kennedy L et al (2018) Comparison of constructive interference in steady-state and T1-weighted MRI sequence at detecting pituitary adenomas in Cushing\u2019s disease patients. J Neurol Surg B 79:593\u2013598. https:\/\/doi.org\/10.1055\/s-0038-1642032","journal-title":"J Neurol Surg B"},{"key":"1236_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/cen.14574","volume":"96","author":"Y Wu","year":"2022","unstructured":"Wu Y, Cai Y, Rui W, Tang Y, Yang Z, He M et al (2022) Contrast-enhanced 3D\u2013T2-weighted SPACE sequence for MRI detection and localization of adrenocorticotropin (ACTH)-secreting pituitary microadenomas. Clin Endocrinol (Oxf) 96:578\u2013588. https:\/\/doi.org\/10.1111\/cen.14574","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1236_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3171\/2009.7.JNS09285","volume":"112","author":"H Ikeda","year":"2010","unstructured":"Ikeda H, Abe T, Watanabe K (2010) Usefulness of composite methionine-positron emission tomography\/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. J Neurosurg 112:750\u2013755. https:\/\/doi.org\/10.3171\/2009.7.JNS09285","journal-title":"J Neurosurg"},{"key":"1236_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11102-021-01160-5","volume":"24","author":"S Berkmann","year":"2021","unstructured":"Berkmann S, Roethlisberger M, Mueller B, Christ-Crain M, Mariani L, Nitzsche E et al (2021) Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET\/MRI. Pituitary 24:878\u2013886. https:\/\/doi.org\/10.1007\/s11102-021-01160-5","journal-title":"Pituitary"},{"key":"1236_CR13","doi-asserted-by":"publisher","first-page":"M107","DOI":"10.1530\/EJE-15-0616","volume":"173","author":"O Koulouri","year":"2015","unstructured":"Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA et al (2015) A role for 11C-methionine PET imaging in ACTH-dependent Cushing\u2019s syndrome. Eur J Endocrinol 173:M107\u2013M120. https:\/\/doi.org\/10.1530\/EJE-15-0616","journal-title":"Eur J Endocrinol"},{"key":"1236_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","volume":"65","author":"J Boyle","year":"2019","unstructured":"Boyle J, Patronas NJ, Smirniotopoulos J, Herscovitch P, Dieckman W, Millo C et al (2019) CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease. Endocrine 65:155\u2013165. https:\/\/doi.org\/10.1007\/s12020-019-01944-7","journal-title":"Endocrine"},{"key":"1236_CR15","doi-asserted-by":"publisher","first-page":"e1816","DOI":"10.1210\/clinem\/dgaa755","volume":"106","author":"R Walia","year":"2021","unstructured":"Walia R, Gupta R, Bhansali A, Pivonello R, Kumar R, Singh H et al (2021) Molecular imaging targeting corticotropin-releasing hormone receptor for corticotropinoma: a changing paradigm. J Clin Endocrinol Metab 106:e1816\u2013e1826. https:\/\/doi.org\/10.1210\/clinem\/dgaa755","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01236-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01236-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01236-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T09:24:42Z","timestamp":1666430682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01236-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01236-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"19 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}